Apimeds Pharmaceuticals US (APUS) Q4 2024 Earnings

Screener

Reported December 31, 2024

EPS-$0.02

Next report

Date not yet announced

Versus estimates

Diluted EPS

Q2 2026-$11.77 Q1 2026-$2.26 Q3 2025-$0.14 Q2 2025-$0.26 Q1 2025-$0.05

Q4 2024-$0.02

FAQ

When did Apimeds Pharmaceuticals US report Q4 2024 earnings?: Apimeds Pharmaceuticals US (APUS) reported Q4 2024 earnings on December 31, 2024.
What were Apimeds Pharmaceuticals US's Q4 2024 revenue and EPS?: Apimeds Pharmaceuticals US reported eps of $-0.02 for Q4 2024.

Ask the moment Apimeds Pharmaceuticals US reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk